These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34596258)

  • 21. Population pharmacokinetic model of Vancomycin based on therapeutic drug monitoring data in critically ill septic patients.
    Kovacevic T; Miljkovic B; Kovacevic P; Dragic S; Momcicevic D; Avram S; Jovanovic M; Vucicevic K
    J Crit Care; 2020 Feb; 55():116-121. PubMed ID: 31715528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Pharmacokinetics of Vancomycin in Critically Ill Children.
    Sridharan K; Al Daylami A; Ajjawi R; Al-Ajooz H; Veeramuthu S
    Eur J Drug Metab Pharmacokinet; 2019 Dec; 44(6):807-816. PubMed ID: 31301023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma and interstitial fluid population pharmacokinetics of vancomycin in critically ill patients with sepsis.
    Abraham J; Sinnollareddy MG; Roberts MS; Williams P; Peake SL; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2019 Feb; 53(2):137-142. PubMed ID: 30296581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
    Adane ED; Herald M; Koura F
    Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis--a population pharmacokinetic study.
    Hennig S; Norris R; Kirkpatrick CM
    Br J Clin Pharmacol; 2008 Apr; 65(4):502-10. PubMed ID: 17995972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients.
    Dhaese SAM; Roberts JA; Carlier M; Verstraete AG; Stove V; De Waele JJ
    Int J Antimicrob Agents; 2018 Apr; 51(4):594-600. PubMed ID: 29277531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Neonates on Extracorporeal Life Support.
    Cies JJ; Moore WS; Nichols K; Knoderer CA; Carella DM; Chopra A
    Pediatr Crit Care Med; 2017 Oct; 18(10):977-985. PubMed ID: 28650363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy.
    Hahn J; Min KL; Kang S; Yang S; Park MS; Wi J; Chang MJ
    Microbiol Spectr; 2021 Dec; 9(3):e0063321. PubMed ID: 34937189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population pharmacokinetics and dosing optimization of vancomycin in children with malignant hematological disease.
    Zhao W; Zhang D; Fakhoury M; Fahd M; Duquesne F; Storme T; Baruchel A; Jacqz-Aigrain E
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3191-9. PubMed ID: 24663023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population Pharmacokinetics and Dosing Simulation of Vancomycin Administered by Continuous Injection in Critically Ill Patient.
    Garreau R; Falquet B; Mioux L; Bourguignon L; Ferry T; Tod M; Wallet F; Friggeri A; Richard JC; Goutelle S
    Antibiotics (Basel); 2021 Oct; 10(10):. PubMed ID: 34680809
    [No Abstract]   [Full Text] [Related]  

  • 31. Population Pharmacokinetic Model to Optimize Cefotaxime Dosing Regimen in Critically Ill Children.
    Béranger A; Oualha M; Urien S; Genuini M; Renolleau S; Aboura R; Hirt D; Heilbronner C; Toubiana J; Tréluyer JM; Benaboud S
    Clin Pharmacokinet; 2018 Jul; 57(7):867-875. PubMed ID: 28980166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vancomycin population pharmacokinetics during extracorporeal membrane oxygenation therapy: a matched cohort study.
    Donadello K; Roberts JA; Cristallini S; Beumier M; Shekar K; Jacobs F; Belhaj A; Vincent JL; de Backer D; Taccone FS
    Crit Care; 2014 Nov; 18(6):632. PubMed ID: 25416535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vancomycin pharmacokinetic-pharmacodynamic parameters to optimize dosage administration in critically ill children.
    Giachetto GA; Telechea HM; Speranza N; Oyarzun M; Nanni L; Menchaca A
    Pediatr Crit Care Med; 2011 Nov; 12(6):e250-4. PubMed ID: 21057350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vancomycin dosing assessment in intensive care unit patients based on a population pharmacokinetic/pharmacodynamic simulation.
    Revilla N; Martín-Suárez A; Pérez MP; González FM; Fernández de Gatta Mdel M
    Br J Clin Pharmacol; 2010 Aug; 70(2):201-12. PubMed ID: 20653673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of Vancomycin in Critically Ill Children: A Systematic Review.
    Akunne OO; Mugabo P; Argent AC
    Eur J Drug Metab Pharmacokinet; 2022 Jan; 47(1):31-48. PubMed ID: 34750740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Race-Based and Non-Race-Based Equations for Kidney Function Estimation in Critically Ill Thai Patients for Vancomycin Dosing.
    Sitaruno S; Santimaleeworagun W; Pattharachayakul S; DeBacker KC; Vattanavanit V; Binyala W; Pai MP
    J Clin Pharmacol; 2022 Oct; 62(10):1215-1226. PubMed ID: 35543614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective evaluation of a continuous infusion vancomycin dosing nomogram in critically ill patients undergoing continuous venovenous haemofiltration.
    Sin JH; Newman K; Elshaboury RH; Yeh DD; de Moya MA; Lin H
    J Antimicrob Chemother; 2018 Jan; 73(1):199-203. PubMed ID: 29040561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Importance of vancomycin loading doses in intermittent infusion regimens.
    Šíma M; Hartinger J; Cikánková T; Slanař O
    J Infect Chemother; 2018 Apr; 24(4):247-250. PubMed ID: 29195829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vancomycin population pharmacokinetics for adult patients with sepsis or septic shock: are current dosing regimens sufficient?
    Heffernan AJ; Germano A; Sime FB; Roberts JA; Kimura E
    Eur J Clin Pharmacol; 2019 Sep; 75(9):1219-1226. PubMed ID: 31154476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
    Chaijamorn W; Jitsurong A; Wiwattanawongsa K; Wanakamanee U; Dandecha P
    Int J Antimicrob Agents; 2011 Aug; 38(2):152-6. PubMed ID: 21636256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.